CHELSEA THERAPEUTICS INT'L LTD
CHTP
CHTP was delisted on the 23rd of June, 2014.
69 hedge funds and large institutions have $79.5M invested in CHELSEA THERAPEUTICS INT'L LTD in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 7 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 12
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
41% more capital invested
Capital invested by funds: $56.3M → $79.5M (+$23.2M)
23% more call options, than puts
Call options by funds: $1.74M | Put options by funds: $1.41M
13% more funds holding
Funds holding: 61 → 69 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.93M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$1.83M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.57M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.3M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$633K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$3.56M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.08M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$470K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$354K |
| 5 |
Goldman Sachs
New York
|
-$345K |
CHTP Hedge Fund Activity: Q3 2013 in Review
69 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q3 2013, worth a combined $79.5M — up 41% from $56.3M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CHTP positions and 7 closed out — a net gain of 10 holders — while 32 added to existing stakes and 12 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $2.93M. The largest seller was Perceptive Advisors, cutting an estimated $3.56M.
- 69 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q3 2013, up from 61 in Q2 2013.
- Funds reported $79.5M of CHELSEA THERAPEUTICS INT'L LTD stock for Q3 2013, up 41% quarter-over-quarter.
- 17 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q3 2013 and 7 closed out, a net change of +10 holders.
- The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q3 2013 was Baker Bros. Advisors, an estimated $2.93M added.
- The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q3 2013 was Perceptive Advisors, an estimated $3.56M sold.
Based on aggregated 13F filings for Q3 2013.